Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Scenarios and speculation

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Feb 05, 2023 10:33am

153 Views

Post# 35267524

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Scenarios and speculation

done my DD. im all in... tired of u dreamers regurgitating the same ole stuff over and over and over. you dont know anything so shut up. just tell us the date since you know it all.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market